5,7-Dichloro-3-isopropylpyrazolo[1,5-a]pyrimidine, 97%, 10g

4-Chloro-2-(trifluoromethyl)benzoic Acid>98.0%(GC)(T)5g

(8-methoxyquinolin-5-yl)boronic acid, 95.0%, 5g

(R)-2-(Oxiran-2-yl)ethan-1-ol, 97%, 5g

N-(3-METHOXY-5-METHYL-2-PYRAZINYL)-2-[4-(1,3,4-OXADIAZOL-2-YL)PHENYL]-3-PYRIDINESULFONAMIDE, 98%, 5mg

4-Bromo-3,5-dichlorobenzaldehyde, 95+%, 500mg

Potassium 2-(quinolin-4-yl)acetate, 95%, 50mg

7-Bromo-1-methyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one, 95%, 1g

Recipiente de reacción con brida plana cilíndrico, graduado (2) Fondo plano, DN 100, 105 mm, Altura, 330 mm, 1 Pieza

(R)-(6,6'-DIMETHOXYBIPHENYL-2,2'-DIYL)BIS[BIS(3,5-DI-TERT-BUTYLPHENYL)PHOSPHINE], 95%, 500mg

2,6-Dibromo-N,N'-bis(2-ethylhexyl)-1,8:4,5-naphthalenetetracarboxdiimide>98.0%(HPLC)5g

2,4-Diamino-6-diallylamino-1,3,5-triazine>98.0%(HPLC)(T)500g

(R)-2-(2-Aminoacetamido)-3-methylbutanoic acid, 95.0%, 1g